Physician profile
Cassandra A Archer
NPI 1871586446
$599.69
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $139 · 2021: $160 · 2022: $21.00 · 2024: $21.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $96.46 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $95.32 | 2019-2021 | |
| Abbvie INC. | $70.80 | 2021-2022 | |
| Sanofi Pasteur INC. | $65.26 | 2019-2021 | |
| Amarin Pharma, INC. | $50.81 | 2020-2021 | |
| Pfizer INC. | $40.52 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $40.18 | 2019-2020 | |
| Novo Nordisk INC | $39.23 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.44 | 2020 | |
| Abbott Laboratories | $21.66 | 2024 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $16.39 | 2019 | |
| Amgen INC. | $15.31 | 2021 | |
| Lilly USA, LLC | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.